Related Experiment Video
Updated: Jul 11, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): a second line treatment
Albiruni Ryan Abdul Razak1, Katy J Chatten, Andrew N Hughes
1Medical Oncology Department, Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle upon Tyne NE4 9XF, United Kingdom. albiruni_ryan@yahoo.co.uk
Abstract:
The role of second line treatment in malignant pleural mesothelioma (MPM) is currently undefined. We present four cases of patients who had durable responses from pemetrexed-based chemotherapy who were retreated with a similar regimen upon progression of their mesothelioma. This case series explores the possible role of retreatment with pemetrexed-based chemotherapy as a second line therapeutic option in MPM.
More Related Videos
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pleural Disorders: Types and Brief Description

